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The mutation pattern of immunoglobulin genes was studied in mice deficient for DNA 
polymerase 
 
 
 
, a translesional polymerase whose inactivation is responsible for the 
xeroderma pigmentosum variant (XP-V) syndrome in humans. Mutations show an 85% 
G/C biased pattern, similar to that reported for XP-V patients. Breeding these mice with 
animals harboring the stop codon mutation of the 129/Olain background in their DNA 
polymerase 
 
 
 
 gene did not alter this pattern further. Although this G/C biased mutation 
profile resembles that of mice deficient in the MSH2 or MSH6 components of the 
mismatch repair complex, the residual A/T mutagenesis of pol
 
 
 
-deficient mice differs 
markedly. This suggests that, in the absence of pol
 
 
 
, the MSH2–MSH6 complex is able 
to recruit another DNA polymerase that is more accurate at copying A/T bases, possibly 
pol
 
 
 
,
 
 
 
to assume its function in hypermutation.
 
Somatic hypermutation of immunoglobulin
genes is initiated by activation-induced cytidine
deaminase (AID; reference 1). Most experimen-
tal evidences suggest that AID initiates this
process by deaminating cytidines into uracils in
DNA (2). Accordingly, overexpression of AID
in fibroblasts is sufficient to induce a G/C-
targeted mutagenesis on a highly transcribed
reporter gene (3). This mutagenesis is supposed
to occur by saturation of the repair capacity of
the cell, generating transition mutations by
replication over the uracils created by deami-
nation. Transversion mutations are likely gen-
erated by one or several translesional poly-
merases that ensure the replication bypass of
abasic sites that failed to be corrected by the
classical base excision repair pathway after ex-
cision of uracils by uracil glycosylases.
In contrast with this “passive” mutagenic
process, hypermutation in activated B cells
generates mutations at all four bases at the Ig
locus (4). This mutagenesis is entirely depen-
dent on the initial handling of the lesion by
only two pathways, one dependent on the
uracil glycosylase UNG, the other one upon a
subset of the mismatch repair complex, its
DNA binding moiety MSH2–MSH6, together
with exonuclease 1 (Exo1; references 5–13).
The UNG pathway appears necessary for gen-
erating most transversion mutations at G/C
bases, whereas the MSH2–MSH6 pathway is
required for a large part of the mutagenesis at
A/T positions.
Translesional DNA polymerases are specific
enzymes, recruited at replication forks stalled in
front of noninstructional DNA lesions, and able
to bypass them with various specificities and
efficiencies (for review see reference 14). More-
over, based on in vitro assays, many of them are
inherently error prone when copying undam-
aged DNA, again with various intrinsic mis-
incorporation specificities, which made them
prime candidates for the Ig gene mutational
process, and several experimental data have in-
deed documented their involvement. The Ig
gene mutation profile of xeroderma pigmento-
sum variant (XP-V) patients, deficient in DNA
polymerase 
 
 
 
 (15), has suggested that this en-
zyme is a major contributor of the MSH2–
MSH6 driven A/T mutagenesis (16–18). The
DNA polymerase 
 
 
 
, which colocalizes with
pol
 
 
 
 at replication foci (19), has been implied in
the Ig gene mutagenesis induced in a Burkitt’s
lymphoma cell line (20). However, inactivation
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of this enzyme in the mouse, by a stop codon present as a nat-
ural mutation of various 129 substrains, failed to show any
phenotype on hypermutation (21). DNA polymerase 
 
 
 
 is pro-
posed to contribute to the overall quantitative efficiency of the
process, but not to any specific pathway (22, 23).
To look for possible differences in the various DNA
polymerases involved between mouse and humans, we inac-
tivated pol
 
 
 
 in the mouse, and analyzed the Ig mutation pat-
tern in the context of the pol
 
 
 
 mutation of the 129/Ola
strain. This analysis confirms the phenotype observed for
pol
 
 
 
 deficiency in humans, which is not altered further in
the presence of the pol
 
 
 
 mutation of the 129 background.
 
RESULTS AND DISCUSSION
 
Inactivation of the mouse 
 
Polh
 
 gene was performed by a
conditional knock-out strategy that introduces loxP sites
flanking exon 4, an exon containing the DE polymerase mo-
tifs conserved in all Y-family polymerases and indispensable
for pol
 
 
 
 catalytic function (Fig. 1 and references 15, 24).
This strategy was designed with the aim of crossing the ani-
mals obtained with mice harboring other DNA repair de-
fects, allowing the follow-up of the B cell lineage in case of
lethality of their combined deficiencies. Deletion of exon 4
was performed here in the targeted embryonic stem (ES) cell
clone, leaving in place a single loxP site and, therefore, min-
imizing disturbance around the gene. The 
 
Xpo5
 
 gene, en-
coding exportin-5 involved in the nuclear export of mi-
croRNAs, indeed initiates 200 bp upstream from the first
 
Polh
 
 exon in opposite transcriptional orientation; affecting
expression of this gene is, therefore, likely to result in an
early embryonic lethal phenotype (25).
The heterozygotes obtained by breeding chimeras with
C57Bl/6 mice were crossed together and screened for the
presence of the stop codon mutation born by the 
 
Poli
 
 gene
from the 129/Ola genetic background of the ES cells. Wild-
type, homozygous pol
 
 
 
-deficient, and double pol
 
 
 
-pol
 
 
 
mutant mice were selected for analysis. Deletion of exon 4
of pol
 
 
 
 resulted at the transcriptional level in the direct splic-
ing of exons 3–5, an out-of-frame junction that introduces a
stop codon 11 amino acids downstream in exon 5 and gen-
erates a truncated pol
 
 
 
 protein of 102 amino acids (Fig. 1
D). Apart from deletion of exon 4, such a truncated protein
would lack domains involved in nuclear localization and re-
pair foci formation (19).
Wild-type, pol
 
 
 
-deficient, and double pol
 
 
 
-pol
 
 
 
 mutant
mice were analyzed for the mutation pattern of their Ig lo-
cus. Different types of sequences were analyzed: intronic se-
quences flanking rearranged J
 
H
 
4 sequences (“J
 
H
 
4 intronic se-
quences”) and a 560-bp region upstream from the repeats of
the S
 
 
 
 core sequence (hereafter referred to as “pre-switch”),
both from Peyer’s patch PNA
 
high
 
 B cells (Table I).
No B cell anomalies were observed in either type of
polymerase-deficient animals. Ig sequences from pol
 
 
 
 
 
/
 
 
 
PNA
 
high
 
 B cells displayed the same specific pattern as those
Figure 1. Disruption of the mouse Polh gene. (A) Scheme of the 
mouse Polh gene encoding DNA polymerase  . (Closed boxes) coding 
exons; (open boxes) noncoding regions. (B) Scheme of the gene targeting 
strategy. Homologous recombination of the gene-targeting construct results 
in the introduction of loxP sites on both sides of exon 4. (C) Screening of 
mouse genotypes: deletion of exon 4 is monitored by a PCR around this 
exon, using primers shown in B. (D) Pol  gene expression in control and 
gene-targeted mice: amplification of pol  transcripts is performed using 
primers in exons 2 and 6, on twofold consecutive dilutions of RT products 
from total spleen RNA. The amplified product in pol  /  animals corresponds 
to the splicing of exons 3–5, which generates an out-of-frame sequence.
 
Table I.
 
Somatic mutations in J
 
H
 
4 intronic sequences and S
 
 
 
 core upstream sequences from normal and mutant mice
 
J
 
H
 
4 intronic sequence (490 bp) S
 
 
 
 core upstream sequence (560 bp)
Controls
 
Pol
 
 
 
   
 
Pol
 
 
 
   
 
 
 
 
 
 
 
pol
 
 
 
   
 
Controls
 
Pol
 
 
 
   
 
Pol
 
 
 
   
 
 
 
 
 
 
 
pol
 
 
 
   
 
Number of sequences 21 71 53 96 122 127
Total length sequenced (bp) 10,290 34,790 25,970 53,760 66,320 71,120
Unmutated sequences (%) 14 17 25 42 46 57
Total number of mutations 124 241 129 147 160 122
Number of deletions and insertions 2 4 0 4 3 2
Mutation frequency per total sequences
(per 100 bp)
1.2 0.7 0.5 0.3 0.2 0.2
Mutation frequency per mutated sequences
(per 100 bp)
1.4 0.8 0.7 0.5 0.4 0.4 
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obtained from memory B cells of XP-V patients; i.e., a
marked reduction of mutations at A/T base pairs: 86.1%
mutations at G/C base pairs for the J
 
H
 
4 intron and 88.6% for
the pre-switch sequence (vs. 89.3 and 89.8% for the corre-
sponding Ig gene sequences in XP-V patients; Figs. 2 and 3,
Table II, and reference 17). Mutation frequencies were
somewhat lower for pol
 
 
 
-deficient animals compared with
wild type when J
 
H
 
4 intronic sequences are considered, but
similar for the pre-switch sequences. Such a quantitative dis-
sociation has been described for MSH6- and for UNG/
MSH2-deficient animals (5, 13).
We next compared the mutation profile of mice harbor-
ing both pol
 
 
 
 and pol
 
 
 
 inactivation. These profiles appear
extremely similar, either in their distribution along the se-
quence (shown for the pre-switch sequence in Fig. 3 C), or
in their base substitution characteristics (Figs. 2 A and 3 A).
The lack of phenotype of pol
 
 
 
-deficient mice on Ig gene hy-
permutation is, therefore, not due to a compensatory role of
pol
 
 
 
 in this specific strain.
All further analyses were, therefore, performed on
pooled data from both types of mutant mice, allowing us to
compare larger databases (366 mutations for the J
 
H
 
4 intron
and 277 for the pre-switch sequence). The targeting was
slightly more pronounced for C than for G, in particular for
the pre-switch sequence. Such an increase has been de-
scribed in switch junctions from XP-V patients (18). How-
ever, among the three types of sequences that we have ana-
lyzed in similar patients, we could not observe this bias in
either switch junctions or J
 
H
 
4 introns, the specific increase in
C mutations being only significant in pre-switch sequences
from XP-V individuals (17). The general relevance of this
observation is, therefore, difficult to assess at this stage.
Moreover, among G/C mutations, no difference from wild
type is noticeable in the relative proportion of transitions and
transversions (Table II).
MSH2 deficiency, together with defects in MSH6 and
Exo1, results in a similar bias toward G/C mutagenesis (7–
13). We, therefore, wanted to compare the mutation pattern
in the J
 
H
 
4 intronic sequence between 
 
Msh2
 
 
 
/
 
 
 
 and 
 
Polh
 
 
 
/
 
 
 
animals. This pattern was established using data from both
MSH2- and Exo1-deficient animals, as well as MSH2-ATPase
mutant mice (326 mutations), taking into account only data
obtained using Pfu polymerase, to exclude any contribution
of less accurate enzymes whose intrinsic error spectrum
might specifically impinge on the A/T pattern. At G/C base
pairs, these mutant mice show a strong bias toward transi-
Figure 2. Distribution of mutations in the VHDJH4 flanking 
sequence (“JH4 intronic region”) of Peyer’s patches PNAhigh B cells 
from pol - and pol -pol -deficient mice. (A) Pattern of nucleotide 
substitution in control mice (two animals), pol -deficient mice (three 
animals), pol - and pol -deficient mice (two animals), and from all mutant 
animals together. Data are given as percent substitution after correction 
for base composition (490 bp starting from the exon/intron border: A, 26.3%; 
C, 14.9%; G, 27.4%; T, 31.4%). (B) Accumulation of mutations in individual 
JH4 intronic sequences. The distribution of sequences harboring a given 
number of mutations relative to the total number of mutated sequences 
is represented for the three mouse genotypes.
 
Table II.
 
Pattern of nucleotide changes in J
 
H
 
4 intronic sequences of 
normal, pol
 
 
 
-, and MSH2-deficient mice
 
Within G/C Within A/T
Trans. Transv. Trans. Transv.
GC:AT
Transitions:
transversions
G/A
C/T
G/T
C/A
G/C
C/G
A/G
T/C
A/T
T/A
A/C
T/G
 
Mouse
Controls 1
 
a
 
44.3:55.7 53.7:46.3 61.4 18.5 20.1 47.6 26.2 26.2
Controls 1
 
b
 
49.9:50.1 53.3:46.7 54.5 16.8 28.7 52.1 25.9 22.0
 
Pol
 
 
 
   
 
c
 
85.5:14.5
 
51.3:48.7 57.1 12.7 30.2
 
17.2
 
26.2
 
56.2
 
Msh2
 
   
 
d
 
87.0:13.0 71.2:28.8 74.0
 
14.0 12.0 52.7 25.7 21.6
Human
Controls 1
 
e
 
46.0:54.0 51.2:48.8 55.4 16.5 28.1 47.6 25.0 27.4
 
XP-V
 
e
 
89.3:10.7
 
46.6:53.4 51.1 17.1 31.8
 
9.4
 
36.4
 
54.2
 
Values in bold represent significant differences from controls discussed in the text.
 
a
 
This study (122 mutations).
 
b
 
From a larger sample (334 mutations; reference 36).
 
c
 
This study, data from all deficient mice together (366 mutations).
 
d
 
Data from mice deficient in the MSH2-dependent pathway (
 
Msh2
 
   
 
, 
 
Exo1
 
   
 
, 
 
Msh2
 
G674A
 
) were pooled (326 mutations obtained by Pfu polymerase; references 8, 
11, 12).
 
e
 
From ref. 17 (168 mutations). 
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tions, which has been interpreted as an increased replicative
bypass of uracils, the absence of the mismatch-binding com-
plex leading to an increased fraction of deaminated bases es-
caping detection and repair. 
 
Polh
 
 
 
/
 
 
 
  animals, in contrast,
show a transition/transversion distribution at G/C bases sim-
ilar to controls. Strikingly, the mutation pattern at A/T bases
pairs shows the reverse situation. MSH2 deficiency shows a
distribution similar to wild type, whereas pol  deficiency re-
sults in a strong transversion bias. This transversion bias is
consistent enough to emerge from both types of sequences
analyzed (JH4 and pre-switch), and in both mouse and hu-
man pol  deficiencies (Table II). Moreover, among trans-
versions at A/T bases, most of them are A to C or T to G
changes, which represent more than half of all A/T muta-
tions. Such a mutation bias has been described for DNA
polymerase   (26, 27). It is thus possible that, in the absence
of pol , the mismatch binding complex is able to recruit a
different translesional enzyme, which, due to its specific mis-
incorporation pattern, would be less mutagenic at A/T base
pairs, leading to a lower frequency of A/T mutations with a
specific transversion bias. Because pol -deficient animals do
not harbor the slightest alteration of their A/T mutation pat-
tern (28), it is probable that this enzyme is not a normal actor
of the Ig gene mutation process, being on duty only in case
of absence of the regular partner of the MSH2–MSH6 com-
plex (i.e., pol ).
Figure 3. Distribution of mutations in the S  core upstream region 
(pre-switch) of Peyer’s patches PNAhigh B cells from pol - and pol -
pol -deficient mice. (A) Pattern of nucleotide substitution from the same 
control and mutant animals described in Fig. 2. Base composition: 560 bp; 
A, 33.2%; C, 16.4%; G, 27.5%; T, 22.9%. (B) Accumulation of mutations in 
individual pre-switch sequences. Same representation as in Fig. 2 B. 
(C) Distribution of mutations along the pre-switch sequence. Mutations 
from pol -deficient mice are listed above the sequence, and mutations 
from double-deficient mice are listed below the sequence. “G” within 
RGYW motifs and “C” within WRCY motifs are underlined.JEM VOL. 201, April 18, 2005 1195
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Pol  is another enzyme with such a transversion bias
(29). However, contrary to pol  and pol , its preferred mis-
incorporation is at copying A, and not T. It is therefore un-
likely, in the mouse at least, that pol  could generate the A
over T bias of mutations in JH4 sequences, present in control
mice and conserved in pol -deficient animals.
UNG and MSH2–MSH6 are the only two repair path-
ways handling uracils generated by AID during Ig gene hy-
permutation. The model of Neuberger et al. (5) posits that
G/C mutations are introduced by replication over the uracils
or the abasic sites generated by uracil glycosylase, both events
occurring on the DNA strand opposed to the lesion and
without repair. Replication over the abasic site would in-
volve translesional DNA polymerases in their “classical” role
of damage bypass. Effectively, in the AID-dependent muta-
tions observed in the chicken cell line DT40 that are almost
entirely restricted to G/C bases, Rev1 has been proposed to
be the major enzyme involved (30). As the mutation pattern
of DT40 is more biased toward G to C and C to G transver-
sions (the hallmark of Rev1) than it is in the mouse, it is so
far unclear how many translesional polymerases are involved
in the G/C mutation pattern in mouse (and human) B cells.
Mutations at A/T bases are more difficult to explain on a
strict replication mode within this model.
In another scenario, the MSH2–MSH6 complex would
recruit pol  for an error-prone repair of the lesion (i.e., on
the same DNA strand) that would remove the uracil or the
abasic site and create mismatches at nearby A/T bases be-
cause this enzyme is inherently more mutagenic at copying
Ts. Along this line, specific modifications of AID in hyper-
mutating B cells might also actively recruit UNG at the site
of the lesion (31), driving the G/C mutagenesis to proceed
differently from a strict saturation of the normal repair of
uracils. In such a scheme, the dichotomy between translesion
bypass and error-prone repair for the G/C versus A/T muta-
tion pathways might have to be reassessed.
The absence of phenotype of the pol  mutation of the
129 strains obviously questions the relevance of the pol -
dependent mutagenic process that we described in the BL2
Burkitt’s lymphoma cell line (20). In fact, it has been re-
ported that such a pol -dependent mutagenesis can be in-
duced at the Ig locus in B cell lines infected by the hepatitis
C virus (32). These mutations would be related to the spe-
cific metabolic alterations brought upon infection by this
oncogenic virus, alterations that may be shared by many B
cell lymphomas (33). Alternatively, inactivation of pol  in
the 129/Ola mouse strain might show leakiness, in particular
in activated B cells, by either read-trough of the stop codon
or alternative splicing. A classical inactivation of the Poli
gene and the analysis of mice cumulating several deficiencies
in the activities involved in hypermutation might contribute
to address these issues.
MATERIALS AND METHODS
Construction of targeting vectors. Three fragments from the POLH
locus were amplified and cloned in the pFlox vector (34): fragment 1, 5 
flank; fragment 2, exon 4; and fragment 3, 3  flank. Construction of the tar-
geting vector and screening of recombinant clones are described in supple-
mental Materials and methods (available at http://www.jem.org/cgi/
content/full/jem.20050292/DC1). Transfection of E14.1 ES cells was per-
formed as described (35). One recombinant clone was obtained out of 287
ES clones, and subjected to Cre-mediated excision to generate exon
4–deleted clones.
Analysis of gene-targeted mice. Screening of gene targeted mice was
performed by PCR around exon 4 (described in Fig. 1) using the following
primers: 5 -screen, 5 -GTCTCCCCAGATGTATCTCC-3 , and 3 -screen,
5 -GCATTGTACACCTGTGGTCC-3  (45 s at 94 C, 30 s at 59 C, 3 min at
72 C, 40 cycles with Taq polymerase; Biolabs). The pol  mutation of the
129/Ola background was screened by direct sequencing of a 540-bp geno-
mic fragment encompassing exon 2 (amplified by iota-exon 2-5 , 5 -TTA-
AAGCAGGACTGAAGACC-3 ; iota-exon 2-3 , 5 -CACATTTACTC-
TCGGTTGCA-3 , for 15 s at 98 C, 30 s at 60 C, 15 s at 72 C, 40 cycles
with Phusion DNA polymerase; Finnzymes). Pol  mRNA expression was
analyzed by RT-PCR (Stratascript; Stratagene), using splenic RNA ex-
tracted by the QIAGEN RNeasy kit and PCR primers located in exons 2
and 6 (exon 2, 5 -GGGCAGAATCGAGTGGTTGC-3 ; exon 6 reverse,
5 -GCGGTTGGGCTTATTTAGTCC-3 , 30 s at 95 C, 90 s at 68 C, 40
cycles with Advantage II polymerase mix; CLONTECH Laboratories, Inc.).
Analysis of mutations in the Ig locus. B220  PNAhigh B cells from
Peyer’s patches were isolated from 3–4-mo-old animals as described previ-
ously (8). Amplification of the JH4 intronic sequence flanking rearranged VH
genes was performed using a mixture of primers amplifying most VH gene
families described (compiled from the mouse V gene IMGT database, http://
imgt.cines.fr): V1-FR3, 5 -GAGGACTCTGCRGTCTATTWCTGTGC-
3 ; V5-FR3, 5 -GAGGACACRGCCATGTATTACTGTGC-3 ; V3-FR3,
5 -GAGGACACACCCACATATTACTGTGC-3 ; V7-FR3, 5 -GAGGA-
CAGTGCCACTTATTACTGTGC-3 ; and V9-FR3, 5 -ATGAGGA-
CATGGCTACATATTTCTGT-3 , respectively, in a 6:3:1:1:1 ratio, and
JH3 , 5 -TGAGACCGAGGCTAGATGCC-3 . PCR was performed on
five aliquots of 500 or 1,000 cells (15 s 98 C, 30 s 64 C, 30 s 72 C for 50 cy-
cles using Phusion DNA polymerase) and 480 bp sequences were determined
using the JH3  primer. A 735-bp fragment upstream from the S  core repeat
sequence was amplified using primers S -5 , 5 -GTTGAGGTACTGAT-
GCTGTC-3  and S -3 , 5 -CCAGCCTAGTTTAGCTTAGC-3  (45 s at
94 C, 30 s at 58 C, 2 min at 72 C, 40 cycles with Pfu Turbo), and a 560-bp
sequence was determined using primer 5 -CTATTCTGGCTCTTCT-
TAAGC-3 . Sequences were obtained with an ABI Prism 3100 Genetic An-
alyzer after cloning in the Zero Blunt vector (Invitrogen).
Online supplemental material. Construction of the targeting vector for
inactivation of the Polh gene, as well as conditions for analysis of the recom-
binant ES clones are described online. Online supplemental material is
available at http://www.jem.org/cgi/content/full/jem.20050292/DC1.
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